Status
Conditions
Treatments
About
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
Full description
The primary objective of this clinical trial is to investigate the effectiveness and safety of intermittent theta burst stimulation ( iTBS) in the cerebellum for individuals with post-stroke cognitive impairment. The trial aims to answer two main questions: (1) What is the effectiveness of iTBS in improving post-stroke cognitive impairment? (2) Is iTBS in the cerebellum safe for individuals with post-stroke cognitive impairment? Participants will undergo iTBS in the cerebellar opposite the lesion site, twice daily for five days. The control group will receive sham rTMS with the same parameters and positions.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key inclusion criteria:
(1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26;
Key exclusion criteria:
(1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy;
Primary purpose
Allocation
Interventional model
Masking
70 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Weili Jia, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal